Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 321

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial

Open access
Comerota, Anthony J., Kearon, Clive, Gu, Chu-Shu, Julian, Jim A., Goldhaber, Samuel Z., Kahn, Susan R., Jaff, Michael R., Razavi, Mahmood K., Kindzelski, Andrei L., Bashir, Riyaz, Patel, Parag, Sharafuddin, Mel, Sichlau, Michael J., Saad, Wael E., Assi, Zakaria, Hofmann, Lawrence V., Kennedy, Margaret, Vedantham, Suresh, For the ATTRACT Trial Investigators · 2019 · Circulation

Abstract

Background: The ATTRACT trial (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis) previously reported that pharmacomechanical catheter–directed thrombolysis (PCDT) did not prevent postthrombotic syndrome (PTS) in patients with acute proximal deep vein thrombosis. In the current analysis, we examine the effect of PCDT in ATTRACT patients with iliofemoral deep vein thrombosis. Methods: Within a large multicenter randomized trial, 391 patients with acute deep vein thrombosis involving the iliac or common femoral veins were randomized to PCDT with anticoagulation versus anticoagulation alone (No-PCDT) and were followed for 24 months to compare short-term and long-term outcomes. Results: Between 6 and 24 months, there was no difference in the occurrence of PTS (Villalta scale ≥5 or ulcer: 49% PCDT versus 51% No-PCDT; risk ratio, 0.95; 95% CI, 0.78–1.15; P =0.59). PCDT led to reduced PTS severity as shown by lower mean Villalta and Venous Clinical Severity Scores ( P <0.01 for comparisons at 6, 12, 18, and 24 months), and fewer patients with moderate-or-severe PTS (Villalta scale ≥10 or ulcer: 18% versus 28%; risk ratio, 0.65; 95% CI, 0.45–0.94; P =0.021) or severe PTS (Villalta scale ≥15 or ulcer: 8.7% versus 15%; risk ratio, 0.57; 95% CI, 0.32–1.01; P =0.048; and Venous Clinical Severity Score ≥8: 6.6% versus 14%; risk ratio, 0.46; 95% CI, 0.24–0.87; P =0.013). From baseline, PCDT led to greater reduction in leg pain and swelling ( P <0.01 for comparisons at 10 and 30 days) and greater improvement in venous disease–specific quality of life (Venous Insufficiency Epidemiological and Economic Study Quality of Life unit difference 5.6 through 24 months, P =0.029), but no difference in generic quality of life ( P >0.2 for comparisons of SF-36 mental and physical component summary scores through 24 months). In patients having PCDT versus No-PCDT, major bleeding within 10 days occurred in 1.5% versus 0.5% ( P =0.32), and recurrent venous thromboembolism over 24 months was observed in 13% versus 9.2% ( P =0.21). Conclusions: In patients with acute iliofemoral deep vein thrombosis, PCDT did not influence the occurrence of PTS or recurrent venous thromboembolism. However, PCDT significantly reduced early leg symptoms and, over 24 months, reduced PTS severity scores, reduced the proportion of patients who developed moderate-or-severe PTS, and resulted in greater improvement in venous disease–specific quality of life. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT00790335.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.118.037425

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 321

Metadata

Authors
Comerota, A. J., Kearon, C., Gu, C.-S., Julian, J. A., Goldhaber, S. Z., Kahn, S. R., Jaff, M. R., Razavi, M. K., Kindzelski, A. L., Bashir, R., Patel, P., Sharafuddin, M., Sichlau, M. J., Saad, W. E., Assi, Z., Hofmann, L. V., Kennedy, M., Vedantham, S., & For the ATTRACT Trial Investigators
Venue
Circulation
Published
2019-02-26
Volume
139
Issue
9
Pages
1162-1173
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2916384180
Cited by
321
References
40
FWCI
28.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial. https://app.cochat.ai/papers/10.1161/circulationaha.118.037425
The paper
Comerota, A. J., Kearon, C., Gu, C.-S., Julian, J. A., Goldhaber, S. Z., Kahn, S. R., Jaff, M. R., Razavi, M. K., Kindzelski, A. L., Bashir, R., Patel, P., Sharafuddin, M., Sichlau, M. J., Saad, W. E., Assi, Z., Hofmann, L. V., Kennedy, M., Vedantham, S., & For the ATTRACT Trial Investigators. (2019). Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial. Circulation. https://doi.org/10.1161/circulationaha.118.037425

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.